X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (318) 318
humans (297) 297
hematology (235) 235
transplantation (233) 233
male (185) 185
female (184) 184
immunology (162) 162
adult (151) 151
bone-marrow-transplantation (141) 141
adolescent (123) 123
oncology (121) 121
middle aged (112) 112
hematopoietic stem cells (101) 101
versus-host-disease (101) 101
transplantation, homologous (100) 100
stem cells (99) 99
child (98) 98
leukemia (92) 92
treatment outcome (90) 90
histocompatibility testing (81) 81
hematopoietic stem cell transplantation - methods (78) 78
hematopoietic stem cell transplantation (73) 73
graft vs host disease - prevention & control (72) 72
child, preschool (69) 69
stem-cell transplantation (67) 67
tissue donors (67) 67
transplantation conditioning - methods (58) 58
young adult (56) 56
acute myeloid-leukemia (54) 54
hematopoietic stem cell transplantation - adverse effects (54) 54
unrelated donors (53) 53
hematology, oncology and palliative medicine (52) 52
bone marrow (51) 51
histocompatibility (50) 50
hla antigens - immunology (50) 50
animals (49) 49
haplotypes (49) 49
disease-free survival (47) 47
stem cell transplantation (47) 47
hla-mismatched/haploidentical blood (46) 46
leukemia - therapy (45) 45
graft survival (44) 44
t cells (44) 44
aged (43) 43
mismatched hla (43) 43
bone marrow transplantation (42) 42
hematologic malignancies (41) 41
analysis (40) 40
care and treatment (40) 40
haploidentical (40) 40
recurrence (40) 40
research (40) 40
acute disease (39) 39
relapse (39) 39
graft vs host disease - etiology (38) 38
graft vs host disease - immunology (38) 38
risk factors (38) 38
transplantation conditioning (38) 38
retrospective studies (37) 37
acute lymphoblastic-leukemia (36) 36
acute-leukemia (36) 36
health aspects (36) 36
survival analysis (36) 36
engraftment (35) 35
donors (34) 34
infant (34) 34
children (33) 33
graft-versus-host disease (33) 33
histocompatibility antigens (33) 33
hla antigens - genetics (33) 33
umbilical-cord blood (33) 33
hla histocompatibility antigens (32) 32
t-cells (32) 32
article (31) 31
survival rate (31) 31
bone-marrow transplantation (30) 30
hematologic neoplasms - therapy (30) 30
mismatched renal-transplantation (30) 30
cancer (29) 29
histocompatibility antigen hla (29) 29
immune reconstitution (29) 29
regulatory t-cells (29) 29
antithymocyte globulin (28) 28
gvhd (28) 28
high-risk (28) 28
lymphocyte depletion (28) 28
graft (27) 27
leukemia, myeloid, acute - therapy (27) 27
mortality (27) 27
versus-host disease (27) 27
pediatrics (26) 26
survival (25) 25
t-lymphocytes - immunology (25) 25
donor lymphocyte infusion (24) 24
hla-identical siblings (24) 24
immunotherapy (24) 24
risk acute-leukemia (24) 24
total-body irradiation (24) 24
usage (24) 24
allografts (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Therapy, ISSN 1525-0016, 10/2017, Volume 25, Issue 10, pp. 2254 - 2269
Journal Article
Clinical Transplantation, ISSN 0902-0063, 03/2012, Volume 26, Issue 2, pp. 284 - 291
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2010, Volume 16, Issue 6, pp. 838 - 847
Recent studies have suggested that coinfusion of mesenchymal stem cells (MSCs) the day of hematopoietic cell transplantation (HCT) might promote engraftment... 
Hematology, Oncology and Palliative Medicine | Graft-versus-host disease | Nonmyeloablative | Graft-versus-tumor effects | Hematopoietic cell transplantation | HLA-mismatched | Mesenchymal stem cells | TOTAL-BODY IRRADIATION | DENDRITIC CELLS | DONOR | HEMATOLOGIC MALIGNANCY PATIENTS | PHASE-II | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | TRANSPLANTATION | SUSTAINED REMISSIONS | HEMATOLOGY | MYCOPHENOLATE-MOFETIL | T-CELLS | PREDICTIVE FACTORS | Peripheral Blood Stem Cell Transplantation - adverse effects | Peripheral Blood Stem Cell Transplantation - methods | Humans | Middle Aged | Male | Mesenchymal Stem Cell Transplantation - adverse effects | Transplantation, Homologous | Mesenchymal Stromal Cells - immunology | Young Adult | Mesenchymal Stromal Cells - cytology | Adult | Female | Transplantation Conditioning - methods | Child | Graft vs Host Disease - diagnosis | HLA Antigens - immunology | Mesenchymal Stromal Cells - metabolism | Graft vs Tumor Effect | Treatment Outcome | Histocompatibility - immunology | Disease Progression | Hematologic Neoplasms - surgery | Mesenchymal Stem Cell Transplantation - methods | Disease-Free Survival | Pilot Projects | Transplantation Chimera - blood | Adolescent | Survival Analysis | Graft Rejection | Graft vs Host Disease - prevention & control | Aged | Cell research | Transplantation | Hematopoietic stem cells | Stem cells | Index Medicus
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2009, Volume 15, Issue 2, pp. 257 - 265
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2006, Volume 12, Issue 10, pp. 1073 - 1084
The major problems in human leukocyte antigen (HLA)-mismatched stem cell transplantation (SCT) are graft failure and graft-versus-host disease (GVHD).... 
Graft-versus-host disease | HLA-mismatched transplantation | Nonmyeloablative stem cell transplantation | Allogeneic stem cell transplantation | SUCCESSFUL ENGRAFTMENT | BONE-MARROW-TRANSPLANTATION | nonmyeloablative stem cell transplantation | MONOCLONAL-ANTIBODY | DONORS | IMMUNOLOGY | VERSUS-HOST-DISEASE | THROMBOTIC MICROANGIOPATHY | CHRONIC GRAFT | TRANSPLANTATION | ACUTE-LEUKEMIA | allogeneic stem cell transplantation | HIGH-RISK | HEMATOLOGY | graft-versus-host disease | T-CELLS | Recurrence | Graft vs Host Disease - epidemiology | Bone Marrow - immunology | Methylprednisolone - therapeutic use | Hematologic Neoplasms - mortality | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Bone Marrow - radiation effects | HLA Antigens - genetics | Antilymphocyte Serum - administration & dosage | Busulfan - administration & dosage | Cytokines - physiology | Transplantation Conditioning - mortality | Incidence | Adult | Female | Graft vs Host Disease - etiology | Myelodysplastic Syndromes - surgery | Myelodysplastic Syndromes - drug therapy | Bone Marrow - drug effects | T-Lymphocytes | Peripheral Blood Stem Cell Transplantation - mortality | Graft Survival | Treatment Outcome | CD4 Lymphocyte Count | Combined Modality Therapy | Vidarabine - analogs & derivatives | Remission Induction | Transplantation, Homologous - immunology | Peripheral Blood Stem Cell Transplantation - statistics & numerical data | Hematologic Neoplasms - surgery | Disease-Free Survival | Tacrolimus - therapeutic use | HLA Antigens - analysis | Myelodysplastic Syndromes - mortality | Hematologic Neoplasms - drug therapy | Family | Graft vs Host Disease - prevention & control | Vidarabine - administration & dosage | Tissue Donors | Histocompatibility | Transplantation | Stem cells | Index Medicus
Journal Article
Journal Article
HLA, ISSN 2059-2302, 07/2017, Volume 90, Issue 1, pp. 43 - 45
Journal Article
HLA, ISSN 2059-2302, 07/2016, Volume 88, Issue 1-2, pp. 35 - 37
In this report we describe a case of somatic mutation in the HLA‐B gene in the tumour cells of a patient with acute myelogenous leukaemia (AML). Routine human... 
somatic mutation | HLA‐B | haematological malignancy | Somatic mutation | HLA-B | Haematological malignancy | MISMATCHED HLA | ALLELE | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | PATHOLOGY | STEM-CELL TRANSPLANTATION | BLAST-SPECIFIC MUTATION | CELL BIOLOGY
Journal Article
Journal Article